Junfeng Sun

430 total citations
19 papers, 341 citations indexed

About

Junfeng Sun is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Junfeng Sun has authored 19 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Junfeng Sun's work include Hormonal and reproductive studies (5 papers), Adipose Tissue and Metabolism (4 papers) and Ion channel regulation and function (3 papers). Junfeng Sun is often cited by papers focused on Hormonal and reproductive studies (5 papers), Adipose Tissue and Metabolism (4 papers) and Ion channel regulation and function (3 papers). Junfeng Sun collaborates with scholars based in China, United States and Russia. Junfeng Sun's co-authors include Junxian Cao, Ying Han, Lu Fu, Fengyue Wang, Ping Zhou, Yu Lou, Yuanshi Li, Zhen Wang, Yi Xu and Xianling Tang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis A General and European Journal of Pharmacology.

In The Last Decade

Junfeng Sun

18 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfeng Sun China 10 133 95 80 51 40 19 341
Chuanshi Xiao China 11 166 1.2× 77 0.8× 37 0.5× 63 1.2× 22 0.6× 24 390
Yuling Tian China 13 168 1.3× 42 0.4× 59 0.7× 52 1.0× 59 1.5× 28 490
Jie Fang China 8 213 1.6× 36 0.4× 108 1.4× 59 1.2× 27 0.7× 25 427
David Mondaca‐Ruff Chile 9 185 1.4× 114 1.2× 41 0.5× 50 1.0× 13 0.3× 16 483
Mohanad Gabani United States 11 160 1.2× 91 1.0× 34 0.4× 83 1.6× 17 0.4× 15 372
Fuqin Tang China 11 208 1.6× 82 0.9× 24 0.3× 60 1.2× 21 0.5× 22 424
Saizhu Wu China 13 168 1.3× 48 0.5× 50 0.6× 75 1.5× 14 0.3× 20 429

Countries citing papers authored by Junfeng Sun

Since Specialization
Citations

This map shows the geographic impact of Junfeng Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfeng Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfeng Sun more than expected).

Fields of papers citing papers by Junfeng Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfeng Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfeng Sun. The network helps show where Junfeng Sun may publish in the future.

Co-authorship network of co-authors of Junfeng Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Junfeng Sun. A scholar is included among the top collaborators of Junfeng Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfeng Sun. Junfeng Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Chao, et al.. (2025). Rational design of S-scheme carbon-doped graphitic carbon nitride/ZnIn2S4 heterojunction with enhanced photocatalytic performance for Carbendazim. Research on Chemical Intermediates. 51(11). 6371–6392. 1 indexed citations
2.
Jiang, Yanyan, et al.. (2025). Efficient alkali-etched g-C3N4/BiVO4 homojunction/heterojunction photocatalyst integrated for the degradation of tetracycline. Applied Catalysis A General. 705. 120436–120436. 1 indexed citations
3.
Zhang, Yuanyuan, Qi Zhang, Xueyao Li, et al.. (2024). Comparison of Injury Severity Score (ISS) and New Injury Severity Score (NISS) in the Evaluation of Thoracic Trauma Patients: A Retrospective Cohort Study. Emergency Medicine International. 2024(1). 4861308–4861308. 1 indexed citations
4.
Rosenthal, Elana, Joseph Carpenter, Ellen Eaton, et al.. (2021). 611. No Source Control: Low Rates of Medication for Opioid Use Disorder in Individuals Hospitalized with Infectious Complications of Injection Opioid Use at Four Academic Medical Centers. Open Forum Infectious Diseases. 8(Supplement_1). S408–S409. 1 indexed citations
5.
Wang, Fengyue, et al.. (2020). Artemisinin suppresses myocardial ischemia–reperfusion injury via NLRP3 inflammasome mechanism. Molecular and Cellular Biochemistry. 474(1-2). 171–180. 42 indexed citations
6.
Sun, Junfeng, et al.. (2020). Long non‑coding RNA LINC00460 predicts poor survival and promotes cell viability in pancreatic cancer. Oncology Letters. 20(2). 1369–1375. 11 indexed citations
7.
Gareev, Ilgiz, et al.. (2019). Extraction of Exosomes from Glioblastoma Multiforme Patients’ Blood Plasma. SHILAP Revista de lepidopterología. 9(3). 234–238.
8.
Yang, Jianying, et al.. (2019). Identification of key candidate genes for pancreatic cancer by bioinformatics analysis. Experimental and Therapeutic Medicine. 18(1). 451–458. 5 indexed citations
9.
Dong, Xiaoying, et al.. (2019). The Relationship of Appetite-Regulating Hormones in the Development of Cardiac Cachexia. International Heart Journal. 60(2). 384–391. 10 indexed citations
10.
Qian, Hua, Xiaoguang Li, Wei Zhang, et al.. (2018). Caspase‑10, matrix metalloproteinase‑9 and total laminin are correlated with the tumor malignancy of clear cell renal cell carcinoma. Oncology Letters. 16(2). 2039–2045. 5 indexed citations
11.
Yang, Jing, et al.. (2017). Guanxintai Exerts Protective Effects on Ischemic Cardiomyocytes by Mitigating Oxidative Stress. Evidence-based Complementary and Alternative Medicine. 2017(1). 4534387–4534387. 9 indexed citations
12.
Sun, Junfeng, Hua Qian, Xiaoguang Li, & Xianling Tang. (2017). QishenYiqi Dripping Pill Improves Heart Failure by Up-Regulation of β2-Adrenergic Receptor Expression.. PubMed. 26(2). 193–199. 2 indexed citations
13.
Lou, Yu, Zhen Wang, Yi Xu, et al.. (2015). Resveratrol prevents doxorubicin-induced cardiotoxicity in H9c2 cells through the inhibition of endoplasmic reticulum stress and the activation of the Sirt1 pathway. International Journal of Molecular Medicine. 36(3). 873–880. 80 indexed citations
14.
Tang, Xianling, Junfeng Sun, Lingling Du, et al.. (2015). Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis. Experimental Eye Research. 143. 110–119. 14 indexed citations
15.
Wang, Fengyue, et al.. (2015). Testosterone replacement attenuates mitochondrial damage in a rat model of myocardial infarction. Journal of Endocrinology. 225(2). 101–111. 37 indexed citations
16.
Fu, Lu, et al.. (2012). Testosterone improves cardiac function and alters angiotensin II receptors in isoproterenol-induced heart failure. Archives of cardiovascular diseases. 105(2). 68–76. 33 indexed citations
17.
Fu, Lu, et al.. (2012). Testosterone replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing expression of cytokines HIF-1a, SDF-1a and VEGF. European Journal of Pharmacology. 684(1-3). 116–124. 49 indexed citations
18.
Sun, Junfeng, et al.. (2011). Testosterone modulation of cardiac β-adrenergic signals in a rat model of heart failure. General and Comparative Endocrinology. 172(3). 518–525. 27 indexed citations
19.
Han, Ying, Lu Fu, Weiju Sun, et al.. (2009). Neuroprotective effects of testosterone upon cardiac sympathetic function in rats with induced heart failure. European Journal of Pharmacology. 619(1-3). 68–74. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026